|
|
|
THURSDAY, MAY 17, 2018 |
|
|
To view the video of the session, click on this icon. |
|
|
|
|
|
09.00
10.00 |
ORAL COMMUNICATIONS
|
|
MORGIOU: |
Chairs: Patrick MALLON, UCD School of Medicine, Dublin - Ireland
Ferdinand WIT, Academic Medical Center, Amsterdam - The Netherlands |
|
|
|
O7. HIV-1 sequences with more predicted glycans in acute infection were associated with the development of higher neutralization breadth
Authors: Mélanie MERBAH (1), Eric SANDERS-BUELL (1), Gina DONOFRIO (1), Yifan LI (1), Meera BOSE (1), Anne-Marie O’SULLIVAN (1), Samantha TOWNSLEY (1), Bonnie SLIKE (1), Hannah KIBUUKA (2), Lucas MAGANGA (3), Sorachai NITAYAPHAN (4), Leigh-Ann ELLER (1), Shelly KREBS (1), Sodsay TOVANABUTRA (1), Nelson MICHAEL (5), Merlin ROBB (1), Morgane ROLLAND (1)
(1) U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Henry M. Jackson Foundation
for the Advancement of Military Medicine, Silver Spring, Md - USA
(2) Makerere University Walter Reed Project, Kampala - Uganda
(3) Mbeya Medical Research Center, Mbeya - Tanzania
(4) AFRIMS, Bangkok - Thailand
(5) U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Md - USA |
|
|
O8. Frequent CXCR4-tropism in newly diagnosed individuals from an HIV-1 F1 subtype cluster rapidly expanding among men who have sex with men in Spain
Authors: Miguel THOMSON, Elena DELGADO, Vanessa MONTERO, Sonia BENITO, Maria-Terasa CUEVAS, Monica SANCHEZ, Cristina CARRERA, Lucia PEREZ-ÁLVAREZ
Carlos III Health Institute, National Center of Microbiology, Majadahonda, Madrid - Spain |
|
|
O9. High incidence of sexually transmitted infections in HIV negative MSM patients: a real-life prospective cohort study
Authors: Patrick PHILIBERT (1), Guillaume PENARANDA (2), Laurent CHICHE (1), Stanislas REBAUDET (1), Claire CAMUS (2), Hacène KHIRI (2), Marion DELORD (1), Julie ALLEMAND-SOURRIEU (1), Philippe HALFON (1,2)
(1) European Hospital, Marseille - France
(2) Alphabio Laboratory, Marseille - France
|
|
|
10. Fungal microbial translocation changes during treated acute and chronic HIV infection
Authors: Vikram MEHRAJ (1), Rayoun RAMENDRA (1), Cecilia COSTINIUK (2), Bertrand LEBOUCHÉ (2), Rosalie PONTE (1), Réjean THOMAS (3), Jason SZABO (4), Pierre COTÉ (4), Roger LEBLANC (5), Jean-Guy BARIL (4), Cécile TREMBLAY (6), Nicole BERNARD (1), Donald C. SHEPPARD (7), Jean-Pierre ROUTY (8)
(1) Research Institute of McGill University Health Center, Montreal - Canada
(2) McGill University Health Center, Chronic Viral Illness Service, Montreal - Canada
(3) L’Actuel Medical Clinic, Montreal - Canada
(4) Quartier Latin Medical Clinic, Montreal - Canada
(5) OPUS Medical Clinic, Montreal - Canada
(6) Montreal University Hospital Research Center, Montreal - Canada
(7) McGill University, Department of Microbiology and Immunology, Montreal - Canada
(8) McGill University, Montreal - Canada |
|
|
11. Two diseases, same person: moving towards a combined HIV and TB continuum of care
Authors: Reuben GRANICH (1), Somya GUPTA (2)
(1) Independent Consultant, San Francisco - USA
(2) Independent Consultant, New Delhi - India |
|
|
|
09.00
10.00 |
LYME DISEASE
|
|
CALLELONGUE: |
Chairs: Adrian CURRAN, University of Barcelona, Barcelona - Spain
Patricia ENEL, Public Health Department / COREVIH, Marseille - France |
|
|
|
Diagnosis, treatment and controversy
Christian PERRONNE, Raymond Poincaré Hospital, Garches - France |
10.00
11.00 |
KEYNOTE LECTURE
|
|
CALLELONGUE: |
Chairs: Christina PSOMAS, Montpellier - France
Jean-Pierre ROUTY, McGill University, Montreal - Canada |
|
|
|
The microbiome
Sergio SERRANO, Ramon y Cajal Hospital, Madrid - Spain |
|
|
O12. Expansion of the enteric virome in untreated HIV infection
Authors: Celia BOUKADIDA, Sandra PINTO-CARDOSO, Ana Paola CARRANCO-ARENAS, Monserrat CHÁVEZ-TORRES, Daniela GARRIDO-RODRÍGUEZ, Amy PERALTA-PRADO, Gustavo REYES-TERÁN
National Institute of Respiratory Diseases, Infectious Diseases Unit, Mexico City - Mexico |
|
|
|
11.30
13.00 |
NEW PATHS ON HIV CURE
|
|
CALLELONGUE: |
Chairs: Sabine KINLOCH, Royal Free Hospital, London - England
Jean-Pierre ROUTY, McGill University, Montreal - Canada |
|
|
|
Shock and kill strategies vs reinforced silencing of latent provirus
Ole Schmeltz SOGAARD, Aarhus University, Aarhus - Denmark |
|
|
What's up in HIV latence and cure?
Christina PSOMAS, Montpellier - France |
|
|
O13. A combination of broad neutralizing antibodies efficiently protects from in vitro cell-associated SHIV162P3 transmission
Authors: Karunasinee SUPHAPHIPHAT (1), Monica TOLAZZI (2), Céline GOMMET (1), Nathalie BOSQUET (1), Gabriella SCARLATTI (2), Roger LE GRAND (1), Mariangela CAVARELLI (1)
(1) CEA-University Paris Sud-INSERM U1184, Infectious Disease Models for Innovative Therapies (IDMIT), Fontenay-aux-Roses - France
(2) San Raffaele Scientific Institute, Viral Evolution and Transmission Unit, Division of Immunology, Transplantation and Infectious Diseases, Milan - Italy |
|
|
O14. Dolutegravir and the universal antiretroviral regimen: good may be the enemy of perfect
Authors: Reuben GRANICH (1), Somya GUPTA (2)
(1) Independent Consultant, San Francisco - USA
(2) Independent Consultant, New Delhi - India |
|
|
O15. Rate of HIV rebound and CD4 T cell kinetics in an aging population on successful antiretroviral therapy
Authors: Abhishek KATIYAR (1), Esther GATHOGO (1), Sabine KINLOCH (1), Margaret JOHNSON (1), Fiona LAMPE (2), Colette SMITH (2)
(1) Royal Free Hospital, London - England
(2) University College London, London - England |
|
|
|
14.30
16.00 |
THERAPEUTIC MANAGEMENT OF COMORBID DISEASES
|
|
CALLELONGUE: |
Chairs: Jose Ignacio BERNARDINO, La Paz University Hospital, Madrid - Spain
Christina PSOMAS, Montpellier - France |
|
|
|
Bone disorders
Patrick MALLON, UCD School of Medicine, Dublin - Ireland |
|
|
Dealing with multimorbidities in HIV
Rosan VAN ZOEST, Institute for Global Health and Development, Amsterdam - The Netherlands |
|
|
HIV and lungs at the time of effective ART
Jean-Pierre ROUTY, McGill University, Montreal - Canada |
|
|
O16. Environmental and occupational exposures as predictors of airflow obstruction in an HIV tertiary care clinic
Authors: Cecilia COSTINIUK (1), Roy NITULESCU (1), Zahra SANEEI (1), Natale WASEF (2), Syim SALAHUDDIN (1), Christina De CASTRO (1), Donatella WASEF (1), Bertrand LEBOUCHE (1), Joseph COX (1), Benjamin SMITH (1), Jason SZABO (1), Mohammad-Ali JENABIAN (3), Jean BOURBEAU (4), Marina KLEIN (1)
(1) McGill University Health Center, Chronic Viral Illness Service, Montreal - Canada
(2) National University of Ireland, Galway - Ireland
(3) University of Quebec at Montreal (UQAM), Montreal - Canada
(4) McGill University Health Center, Division of Respirology, Montreal - Canada |
|
|
O17. Investigating the effect of antiretroviral switch to tenofovir alafenamide on lipid profiles in people living with HIV within the UCD ID cohort
Authors: Aoife LACEY (1), Willard TINAGO (1), Nicholas R. POWER (2), Elena ALVAREZ (1), Alan J. MACKEN (1), Gerard SHEEHAN (2), John S. LAMBERT (2), Aoife G. COTTER (3), Patrick W.G. MALLON (1,2)
(1) University College Dublin, School of Medicine, HIV Molecular Research Group, Dublin - Ireland
(2) Mater Misericordiae University Hospital, Infectious Diseases Department, Dublin - Ireland
(3) University College Dublin, School of Medicine, HIV Molecular Research Group, Infectious Diseases Department, Mater Misericordiae University Hospital, Dublin, Ireland |
|
|
|
16.30
17.30 |
KEYNOTE LECTURE
|
|
CALLELONGUE: |
Chairs: Valérie MARTINEZ, Pitié Salpétrière Hospital, Paris - France
Christina PSOMAS, Montpellier - France |
|
|
|
Immunotherapies and immune check-points
Jean-Philippe SPANO, Pitié-Salpêtrière Hospital, Paris - France |
17.30
18.30 |
WORKSHOP ON PREPS
|
|
CALLELONGUE: |
Chairs: Jose Ignacio BERNARDINO, La Paz University Hospital, Madrid - Spain
Adrian CURRAN, University of Barcelona, Barcelona - Spain |
|
|
|
The decrease of new infections due to early treatment or PrEPs?
Gary WHITLOCK, Chelsea and Westminster Hospital, London - England |
|
|
Generic PrEPs
Andrew HILL, Liverpool University, Liverpool - England |
17.30
18.30 |
WORKSHOP ON STDS
|
|
MORGIOU: |
Chairs: Patricia ENEL, COREVIH, Marseille Hospital, Marseille - France
Patrick PHILIBERT, COREVIH, European Hospital, Marseille - France |
|
|
|
Changing the face of STDs
Dominique TESSIER, Travel Medicine Clinic, Montreal - Canada |
|
|
HPV vaccination: use in prevention and in cure
Deborah KONOPNICKI, Saint Pierre University Hospital, Brussels - Belgium |
|
|
|
INDUSTRY-SPONSORED SYMPOSIA - DAY BY DAY |
|
|
|
13.00
14.30 |
MASTERING THE ART: DESIGNING A VISION FOR FUTURE HIV TREATMENT
|
|
CALLELONGUE: |
INDUSTRY-SPONSORED SYMPOSIUM BY GILEAD
Chair: Anne-Geneviève MARCELIN, Pierre et Marie Curie University, Clermont-Ferrand - France |
|
|
|
Lessons from the history of ART
Jonathan CARTLEDGE, Mortimer Market Center, London - England |
|
|
20:20 - Answering the unknown to shape a vision of treatment
Pierre CORBEAU, Montpellier University, Montpellier - France |
|
|
A virologist’s impression on different treatment strategies
Anne-Geneviève MARCELIN, Pierre et Marie Curie University, Clermont-Ferrand - France |
|